false 0001014763 0001014763 2026-11-12 2026-11-12 0001014763 AIMD:CommonStockParValue0.01PerShareMember 2026-11-12 2026-11-12 0001014763 AIMD:WarrantsToPurchaseCommonStockMember 2026-11-12 2026-11-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 12, 2026

 

AINOS, INC.

 

(Exact name of registrant as specified in its charter)

 

Texas   001-41461   75-1974352

(State or other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

3050 Post Oak Blvd, Suite 510-T80, Houston, TX 77056

(281) 898-6586

(Address and telephone number, including area code, of registrant’s principal executive offices)

 

 

(Former name or former address if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.01 per share   AIMD   The Nasdaq Stock Market LLC
Warrants to purchase Common Stock   AIMDW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 1.01 Entry into a Material Definitive Agreement

 

On November 12, 2026, Ainos, Inc. (the “Company”), entered into an AI NOSE Equipment Sale and Purchase Agreement (the “Agreement”) with ASE Technology Holding Co., Ltd. (“ASE”). Under the Agreement, the Company agreed to sell, and ASE agreed to purchase, a total of 5,000 units of the Company’s AI NOSE equipment (the “Equipment”). The delivery schedule, batches and locations will be confirmed in writing by the parties in accordance with ASE’s deployment plan.

 

Pursuant to the Agreement, the total purchase price of the Equipment is US$9,000,000. ASE is required to pay a deposit equal to 50% of the total purchase price, or US$4,500,000, within 60 days after the date the Agreement is signed. The remaining 50% is payable after the Company completes delivery of all of the Equipment and submits delivery and billing documents to ASE.

 

In addition, pursuant to the Agreement, beginning on the day after the first anniversary of the delivery acceptance date of each unit, and for so long as ASE owns and uses the Equipment, ASE will pay the Company ongoing annual maintenance fee, covering platform usage, technical updates and AI algorithm upgrade services.

 

The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement, an English translation of which is filed with this current report on Form 8-K as Exhibit 10.1 and is hereby incorporated herein by reference.

 

Item 7.01 Regulation FD Disclosure

 

On November 12, 2026, the Company announced the execution of the Agreement with ASE. A copy of the press release issued by the Company in this connection is furnished herewith as Exhibit 99.1.

 

The information furnished with this Item 7.01 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act.

 

Item 9.01 Financial Statement and Exhibits

 

(d) Exhibits.

 

Exhibit No.   Description
10.1*   English Translation of AI Nose Equipment Sale and Purchase Agreement, dated November 12, 2026
99.1   Press Release dated November 12, 2026
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

* Certain portions of this Exhibit were redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The Company hereby agrees to furnish a copy of any omitted portion to the Securities and Exchange Commission upon request.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Ainos, Inc.
   
Date: November 17, 2026 By: /s/ Chun-Hsien Tsai
  Name: Chun-Hsien Tsai
  Title: Chief Executive Officer